Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based oncology management company that entered the public markets through a SPAC merger with DFB Healthcare Acquisitions Corp., a healthcare-focused blank-check vehicle that completed its IPO in 2020. The company operates a network of community-based outpatient cancer care clinics, positioning it within the healthcare services sector. A Form 10-Q bearing accession number 0001104659-20-058786 was filed on May 8, 2020, representing a quarterly disclosure from the SPAC's active reporting period ahead of the de-SPAC transaction closing. The combined entity subsequently listed on Nasdaq under the ticker TOI. For full sponsor details, filing history, and deal-level analytics on TOI and the broader SPAC universe, sign up for complete data access at SpacDesk.